In the BioHarmony Drug Report Database

"Preview" Icon

Deflazacort

Emflaza (deflazacort) is a small molecule pharmaceutical. Deflazacort was first approved as Emflaza on 2017-02-09. It is used to treat duchenne muscular dystrophy and inflammation in the USA.

 

Trade Name

 

Emflaza
 

Common Name

 

deflazacort
 

ChEMBL ID

 

CHEMBL1201891
 

Indication

 

duchenne muscular dystrophy, inflammation
 

Drug Class

 

Image (chem structure or protein)

Deflazacort structure rendering